Live Breaking News & Updates on Carl Kraus

Stay updated with breaking news from Carl kraus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Aquestive Therapeutics Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. ....

Ernie Toth , Steve Wargacki , Jason Butler , Dan Barber , Carl Kraus , Bennett Watson , Ken Marshall , Aquestive Therapeutics Inc , Exchange Commission On , Most Valuable Financial Companies , Aquestive Therapeutics , Call Transcript November , Aquestive Therapeutics Third Quarter , Chief Executive Officer , Chief Financial Officer , Chief Medical Officer , Chief Commercial Officer , Senior Vice President Research , Safe Harbor , Risk Factors , Exchange Commission , Anaphylm Epinephrine Sublingual Film , Home Connected Fitness Equipment , Valuable Financial Companies , Thanks Fran , Chief Commercial ,

Aceragen (ACGN) Announces Recommendation of Data Monitoring Committee in Terra Study

Aceragen (ACGN) Announces Recommendation of Data Monitoring Committee in Terra Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Carl Kraus , Department Of Defense Threat Reduction Agency , Data Monitoring Committee , Aceragen Inc , Chief Medical , Defense Threat Reduction Agency , Fast Track Designation , Orphan Drug Designation , Qualified Infectious Disease Product ,

Idera Bolsters Rare Disease Portfolio with Aceragen Buyout

Two rare disease companies - Idera Pharmaceuticals and Aceragen - are merging to pursue the common goal of an FDA approval that could come as early as 2024. ....

United States , John Taylor , Carl Kraus , John Kirby , Daniel Salain , Us Defense Threat Reduction Agency , Idera Pharmaceuticals , Fast Track , Qualified Infectious Disease Product , Threat Reduction Agency , Chief Medical Officer Carl Kraus , Chief Operating Officer Daniel , General Counsel Bryant Lim , Chief Financial Officer John Kirby , Novaquest The Durham , Dera Bolsters Rare Disease Portfolio With Aceragen Buyout ,

Idera Pharma (IDRA) Acquires Aceragen

Idera Pharma (IDRA) Acquires Aceragen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , James Geraghty , Ron Wooten , Carl Kraus , Daniel Salain , Maxine Gowen , Michael Dougherty , John Taylor , Wedbush Pacgrow , Candy Jordan , Cristina Csimma , John Kirby , Farber Disease , Idera Pharmaceuticals Inc , Fenwick West , Board Of Directors For The Company , Aceragen Inc , Cystic Fibrosis Foundation , Lewis Bockius , Idera Pharmaceuticals , Novaquest Capital Management , Citizens Company , Defense Threat Reduction Agency , Wall Street , Cystic Fibrosis ,

Biopharma deal: NovaQuest-backed Aceragen buys Arrevus

RESEARCH TRIANGLE PARK - The biopharmaceutical company Aceragen, which is backed by NovaQuest Capital Management, announced that it has acquired Arrevus, Inc., ....

John Taylor , Carl Kraus , Arrevus Inc , Novaquest Capital Management , Cystic Fibrosis , Chief Medical ,